Expertise in
4
conditions

Kevin N. Franks

Beckett Street, 
Leeds, ENG, GB 
Expertise in
4
conditions
Beckett Street, 
Leeds, ENG, GB 

Overview

Kevin Franks practices practicing medicine in Leeds, United Kingdom.

Mr. Franks is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Stridor, Gamma Knife Radiosurgery, and Endoscopy.

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Beckett Street, Leeds, ENG, United Kingdom
Other Locations
St James's Institute Of Oncology, St James's Hospital, Leeds, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Open-label Phase II Trial of Consolidation With Nivolumab and Ipilimumab in Limited-stage SCLC After Chemo-radiotherapy
A Randomised Open-label Phase II Trial of Consolidation With Nivolumab and Ipilimumab in Limited-stage SCLC After Chemo-radiotherapy
Enrollment Status: Completed
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer (NSCLC)
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 03, 2023
Intervention Type: Procedure
View 1 Less Clinical Trial

77 Total Publications

Patient-reported EORTC QLQ C-30 global health status decline predicts survival after video-assisted thoracoscopic (VATS) lung resection and stereotactic ablative radiotherapy (SABR): A 5 year follow-up from the Lilac study.
Patient-reported EORTC QLQ C-30 global health status decline predicts survival after video-assisted thoracoscopic (VATS) lung resection and stereotactic ablative radiotherapy (SABR): A 5 year follow-up from the Lilac study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 15, 2025

Frequently Asked Questions about Kevin N. Franks

Is Kevin N. Franks a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Kevin N. Franks is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kevin N. Franks participate in research or clinical trials?

Yes. Kevin N. Franks has published 77 articles and abstracts on conditions like Lung Cancer. You can view a list of Kevin N. Franks's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Franks's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile